Biotech
🔥 Moderna's mRNA Flu Shot Beat the Standard Jab by 27% — and the FDA Nearly Never Reviewed It
The FDA just approved mFlusiva, the first mRNA flu vaccine ever — 26.6% more effective than the standard shot in adults 50+, six months after the agency refused to review it.